SAN FRANCISCO — Use of a functional scoring system dramatically reduced morphine treatment and length of stay among infants with neonatal abstinence syndrome (NAS) compared with the widely used ...

Although morphine is the drug almost exclusively used for neonatal abstinence syndrome (NAS), emerging data suggest that buprenorphine may be an acceptable and perhaps safer alternative. The two ...

A quality improvement (QI) initiative that focused on using non-pharmacologic approaches to care for infants with neonatal abstinence syndrome (NAS) yielded positive short-term outcomes for both the ...

Each year in the US ∼50 000 neonates receive inpatient pharmacotherapy for the treatment of neonatal abstinence syndrome (NAS). The objective of this study is to compare the safety and efficacy of a ...

In the United States, one infant is born every 15 minutes with withdrawal symptoms after being exposed to opioids before birth, according to a new study published in the journal Pediatrics. And from ...

The long-term effects of neonatal abstinence syndrome (NAS) are not well known, but some research suggests it can continue to affect a child into adolescence. NAS refers to a group of conditions an ...

NAS is a serious condition for newborns, but there is an extensive medical support system to help you and your baby through this tough time. Anyone who has ever been pregnant knows that this stage in ...